Polaris AI Pharma Corp. (KOSDAQ:041910)

Polaris AI Pharma Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Sep 30, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Operating Revenue	63,935	60,401	61,324	46,490	40,336	38,214
Other Revenue	-0	-	-	-	-	0
Revenue	63,935	60,401	61,324	46,490	40,336	38,214
Revenue Growth (YoY)	8.69%	-1.50%	31.91%	15.26%	5.55%	-11.94%
Cost of Revenue	51,063	46,617	43,991	33,541	30,536	27,159
Gross Profit	12,872	13,784	17,333	12,948	9,800	11,054
Selling, General & Admin	6,151	5,888	5,484	5,266	4,338	4,504
Research & Development	2,964	3,194	3,301	3,281	3,567	3,287
Amortization of Goodwill & Intangibles	48.76	46.82	60.79	90.18	125.66	149.84
Other Operating Expenses	195.31	176.47	170.64	188.87	116.02	143.66
Operating Expenses	9,711	9,578	9,099	9,220	8,250	8,187
Operating Income	3,161	4,205	8,234	3,728	1,550	2,867
Interest Expense	-21.85	-6.28	-11.2	-16.13	-88.83	-223.97
Interest & Investment Income	459.88	328.61	429.25	520.1	267.86	96.72
Earnings From Equity Investments	-296.96	2,362	156.36	-	-	-
Currency Exchange Gain (Loss)	186.99	773.33	-591.14	986.19	847.02	-1,827
Other Non Operating Income (Expenses)	378.85	345.05	78.61	231.48	442.57	-43.66
EBT Excluding Unusual Items	3,868	8,008	8,295	5,450	3,018	868.95
Gain (Loss) on Sale of Investments	-3,672	-288.7	12,098	13,622	4,942	1,854
Gain (Loss) on Sale of Assets	61.13	53.58	17.71	-16.07	4.42	-6.62
Asset Writedown	-	-	-1,020	-	-	-
Pretax Income	256.35	7,773	19,391	19,056	7,965	2,717
Income Tax Expense	-733.13	898.21	3,659	3,828	1,375	-9.42
Net Income	989.48	6,875	15,733	15,228	6,590	2,726
Net Income to Common	989.48	6,875	15,733	15,228	6,590	2,726
Net Income Growth	-92.80%	-56.30%	3.31%	131.09%	141.71%	-34.27%
Shares Outstanding (Basic)	12	12	12	12	12	12
Shares Outstanding (Diluted)	12	12	12	12	12	12
Shares Change (YoY)	-	-	-	-1.33%	1.60%	-1.97%
EPS (Basic)	84.72	588.60	1346.96	1303.77	564.67	237.00
EPS (Diluted)	84.72	588.60	1346.96	1303.77	557.00	234.00
EPS Growth	-92.80%	-56.30%	3.31%	134.07%	138.03%	-32.95%
Free Cash Flow	-4,694	-1,395	2,510	3,165	6,784	6,298
Free Cash Flow Per Share	-401.90	-119.41	214.91	270.94	573.07	540.59
Dividend Per Share	100.000	100.000	100.000	100.000	50.000	-
Dividend Growth	-	-	-	100.00%	-	-
Gross Margin	20.13%	22.82%	28.27%	27.85%	24.30%	28.93%
Operating Margin	4.94%	6.96%	13.43%	8.02%	3.84%	7.50%
Profit Margin	1.55%	11.38%	25.66%	32.76%	16.34%	7.13%
Free Cash Flow Margin	-7.34%	-2.31%	4.09%	6.81%	16.82%	16.48%
EBITDA	5,778	6,879	10,908	6,475	4,288	6,583
EBITDA Margin	9.04%	11.39%	17.79%	13.93%	10.63%	17.23%
D&A For EBITDA	2,617	2,674	2,675	2,747	2,738	3,716
EBIT	3,161	4,205	8,234	3,728	1,550	2,867
EBIT Margin	4.94%	6.96%	13.43%	8.02%	3.84%	7.50%
Effective Tax Rate	-	11.55%	18.87%	20.09%	17.27%	-
Advertising Expenses	-	76.42	92.28	272.03	278.89	264.45

Source: S&P Global Market Intelligence. Standard template. Financial Sources.